Novel Nucleosides, CMCP and CFCP, Potently Block the Infectivity and Replication of Wild-type and Drug-resistant HBVs in Culture and in Human-liver-chimeric Mice and Show Potential QW or Q2W.
Novel Nucleosides, CMCP and CFCP, Potently Block the Infectivity and Replication of Wild-type and Drug-resistant HBVs in Culture and in Human-liver-chimeric Mice and Show Potential QW or Q2W.
复制标题
新型核苷 CMCP 和 CFCP 可有效阻断培养物和人肝嵌合小鼠中野生型和耐药 HBV 的感染性和复制，并显示出 QW 或 Q2W 潜力。
DOI：
--
复制
发表时间：
2017
期刊：
影响因子：
--
通讯作者：
Mitsuya H.
中科院分区：
文献类型：
--
作者：
Higashi-kuwata N;Hayashi S;Kumamoto H;Kohgo S;Das D;Bulut H;Sarafianos S;Tanaka Y;Mitsuya H.
